112 related articles for article (PubMed ID: 7719142)
1. Malignant hyperthermia in a patient with Becker muscular dystrophy: dystrophin analysis and caffeine contracture study.
Ohkoshi N; Yoshizawa T; Mizusawa H; Shoji S; Toyama M; Iida K; Sugishita Y; Hamano K; Takagi A; Goto K
Neuromuscul Disord; 1995 Jan; 5(1):53-8. PubMed ID: 7719142
[TBL] [Abstract][Full Text] [Related]
2. [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers].
Takagi A
Rinsho Shinkeigaku; 2000 May; 40(5):423-7. PubMed ID: 11002722
[TBL] [Abstract][Full Text] [Related]
3. [Clinical implications of enhanced caffeine contracture in malignant hyperthermia (MH) and Duchenne muscular dystrophy (DMD)].
Takagi A; Kojima S; Araki M
Rinsho Shinkeigaku; 1989 Mar; 29(3):301-5. PubMed ID: 2752656
[TBL] [Abstract][Full Text] [Related]
4. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
[TBL] [Abstract][Full Text] [Related]
6. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry.
Oliveira AS; Gabbai AA; Schmidt B; Kiyomoto BH; Lima JG; Minetti C; Bonilla E
Arq Neuropsiquiatr; 1992 Dec; 50(4):478-85. PubMed ID: 1309152
[TBL] [Abstract][Full Text] [Related]
7. Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study.
Mader N; Gilly H; Bittner RE
Br J Anaesth; 1997 Jul; 79(1):125-7. PubMed ID: 9301401
[TBL] [Abstract][Full Text] [Related]
8. Absence of malignant hyperthermia contractures in Becker-Duchenne dystrophy at age 2.
Gronert GA; Fowler W; Cardinet GH; Grix A; Ellis WG; Schwartz MZ
Muscle Nerve; 1992 Jan; 15(1):52-6. PubMed ID: 1732762
[TBL] [Abstract][Full Text] [Related]
9. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
Slater CR; Nicholson LV
J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
[TBL] [Abstract][Full Text] [Related]
10. [A case of severe Becker muscular dystrophy diagnosed in early childhood--correlation between clinical severity and dystrophin testing].
Ishikawa Y; Ishikawa Y; Sumitani S; Minami R
No To Hattatsu; 1995 Jan; 27(1):53-7. PubMed ID: 7873253
[TBL] [Abstract][Full Text] [Related]
11. Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining.
Chevron MP; Tuffery S; Echenne B; Demaille J; Claustres M
Neuromuscul Disord; 1992; 2(1):47-50. PubMed ID: 1525558
[TBL] [Abstract][Full Text] [Related]
12. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
[TBL] [Abstract][Full Text] [Related]
13. Dystrophin-related protein in Becker muscular dystrophy.
Higuchi I; Niiyama T; Fukunaga H; Nakamura K; Nakagawa M; Osame M
Intern Med; 1994 Jun; 33(6):334-6. PubMed ID: 7919618
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic Becker muscular dystrophy: expression of dystrophin and dystrophin-related protein.
Tachi N; Wakai S; Watanabe Y; Ohya K; Chiba S
Pediatr Neurol; 1993; 9(3):207-9. PubMed ID: 8352853
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
[TBL] [Abstract][Full Text] [Related]
16. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
17. [Detection of dystrophin with anti-peptide antibodies].
Takeda A; Jimi T; Misugi N; Miyake S; Kumagai T; Nakamura Y; Wakayama Y
Rinsho Byori; 1992 Sep; 40(9):953-8. PubMed ID: 1434031
[TBL] [Abstract][Full Text] [Related]
18. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
19. Muscle histology in Becker muscular dystrophy.
Kaido M; Arahata K; Hoffman EP; Nonaka I; Sugita H
Muscle Nerve; 1991 Nov; 14(11):1067-73. PubMed ID: 1745279
[TBL] [Abstract][Full Text] [Related]
20. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy.
Maeda M; Nakao S; Miyazato H; Setoguchi M; Arima S; Higuchi I; Osame M; Taira A; Nomoto K; Toda H
Am Heart J; 1995 Apr; 129(4):702-7. PubMed ID: 7900621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
